On the road to epigenetic therapy.
In this issue of the Biomedical Journal, we examine how far the explosion of epigenetic studies in recent years has translated to benefits for patients in the clinic, and we highlight an original study suggesting that increased vegetable intake protects against osteoporotic fractures. We also hear several opinions on the use, or perhaps misuse, of Impact Factor and what the future should hold for this publication metric.
Staff Writer at the Biomedical Journal, 56 Dronningens Gate, 7012 Trondheim, Norway. Electronic address: ewalton86@gmail.com.
Emma L
EL
Walton
D057890:Epigenomics; D006801:Humans; D055811:Journal Impact Factor; D009369:Neoplasms / Q000628:therapy*; D010024:Osteoporosis / Q000628:therapy*; D058866:Osteoporotic Fractures / Q000378:metabolism*; D012307:Risk Factors
Cancer; Epigenetics; Epimedicine; Fall risk; Osteoporosis